James F. Young, Director at NOVAVAX INC (NVAX), sold 20,000 shares at $228.42 ($4.6M) on 2021-03-23, disclosed to the SEC on 2021-03-25.
Open-market sale of $4.6M NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $227.43 | 4,434 | $1.0M | 22.1% |
| 2 | $227.43 | 4,434 | $1.0M | 22.1% |
| 3 | $228.42 | 3,120 | $713K | 15.6% |
| 4 | $228.42 | 3,120 | $713K | 15.6% |
| 5 | $229.41 | 2,446 | $561K | 12.3% |
| 6 | $229.41 | 2,446 |
| $561K |
| 12.3% |
| Total | $228.22 avg | 20,000 | $4.6M | 100% |
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |